A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate huntington disease: HORIZON investigators of the huntington study group and european huntington's disease network
HORIZON Investigators of the Huntington Study Group and European Huntington's Disease Network
Research output: Contribution to journal › Article › peer-review
19Scopus
citations
Fingerprint
Dive into the research topics of 'A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate huntington disease: HORIZON investigators of the huntington study group and european huntington's disease network'. Together they form a unique fingerprint.